Status:
COMPLETED
Efficacy of Psidii Guava's Extract For COVID-19
Lead Sponsor:
Faculty of Medicine Baiturrahmah University
Conditions:
Covid19
Eligibility:
All Genders
13-59 years
Phase:
PHASE3
Brief Summary
This study was an experimental, randomized clinical trial, with a parallel design, with aims were seeing the effectiveness of extracted Psidii guava on white blood cells (WBCs) count, neutrophil, lymp...
Detailed Description
There will be 2 groups of treatment; each group will consist of 45 subjects with the treatment regimens maximal for 4 weeks. The treatment I: 2 capsules of Extract Psidii guava, three times daily. Tr...
Eligibility Criteria
Inclusion
- Male or female
- Confirmed positive COVID-19 mild and symptomless
- Aged 13 - 59 years
- Willing to take part in the study and sign an informed consent
Exclusion
- Not willing to join the study
- History of allergy to the research drug (extract Psidii guava)
Key Trial Info
Start Date :
June 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04810728
Start Date
June 20 2020
End Date
January 30 2021
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Baiturrahmah University
Padang, West Sumatera, Indonesia, 25586